Inventor
TURNER SEAN C
US23 patents
⚠️ This page may combine multiple inventors who share the name “TURNER SEAN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
6 patentsUS7129235B2Oct 31, 2006
Amides useful for treating pain
ABBOTT LAB32 citations92
US6933311B2Aug 23, 2005
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ABBOTT LAB24 citations92
US7348343B2Mar 25, 2008
Amides useful for treating pain
ABBOTT LAB8 citations73
US7335678B2Feb 26, 2008
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor
ABBOTT LAB8 citations73
US7074805B2Jul 11, 2006
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ABBOTT LAB10 citations73
US7875627B2Jan 25, 2011
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
ABBOTT LAB4 citations62
ABBOTT GMBH & CO KG
5 patentsUS7320979B2Jan 22, 2008
N-[(piperazinyl)hetaryl]arylsulfonamide compounds
ABBOTT GMBH & CO KG7 citations71
US7851463B2Dec 14, 2010
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
ABBOTT GMBH & CO KG2 citations61
US7834048B2Nov 16, 2010
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
ABBOTT GMBH & CO KG0 citations42
US7759397B2Jul 20, 2010
6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
ABBOTT GMBH & CO KG0 citations42
US7994160B2Aug 9, 2011
Pyridazine compounds as glycogen synthase kinase 3 inhibitors
ABBOTT GMBH & CO KG0 citations38
DRESCHER KARLA
4 patentsUS8969552B2Mar 3, 2015
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DRESCHER KARLA2 citations60
US8232426B2Jul 31, 2012
Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DRESCHER KARLA1 citations50
US8470810B2Jun 25, 2013
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DRESCHER KARLA0 citations49
US8486984B2Jul 16, 2013
Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DRESCHER KARLA0 citations39
AKRITOPOULOU-ZANZE IRINI
3 patentsUS8648069B2Feb 11, 2014
5-substituted indazoles as kinase inhibitors
AKRITOPOULOU-ZANZE IRINI44 citations90
US9187483B2Nov 17, 2015
Modulators of 5-HT receptors and methods of use thereof
AKRITOPOULOU-ZANZE IRINI0 citations47
US8846951B2Sep 30, 2014
Modulators of 5-HT receptors and methods of use thereof
AKRITOPOULOU-ZANZE IRINI0 citations36